Descriptive Analysis of Group A in Skin Swabs and Acute Rheumatic Fever, Auckland, New Zealand, 2010-2016

Overview

Journal Lancet Reg Health West Pac

Date 2021 Jul 30

PMID 34327427

Citations 14

Authors

Sally Thomas

Julie Bennett

Susan Jack

Jane Oliver

Gordon Purdie

Arlo Upton

Michael G Baker

Affiliations

Soon will be listed here.

Abstract

Background: Group A (GAS) can trigger an immune-mediated response resulting in acute rheumatic fever (ARF). Historically, ARF has been considered a consequence of preceding GAS pharyngitis, but increasing evidence suggests that GAS skin infections may be a driver. Data on the primary care burden of GAS skin infection are limited. This paper aims to describe and compare the prevalence and distribution of GAS detection in skin swabs and ARF rates in the Auckland population.

Methods: This cross-sectional study used all laboratory skin swab data from people who had a skin swab taken as a result of a consultation with a health professional in the Auckland region (2010-2016). Initial primary hospitalisations for ARF were identified and all data were linked using unique patient identifiers to patient's age, prioritised ethnicity, sex, and socio-economic status.

Findings: 377,410 skin swabs from 239,494 individuals were included. 12·8% of swabs were GAS positive, an annual incidence of 4·8 per 1,000 person-years. Māori and Pacific Peoples under 20 years of age had markedly higher GAS detection in skin swabs (RR 4·0; 95% CI 3·9-4·2: RR 6·8; 95% CI 6·6-7·0) and significantly higher ARF rates (RR 30·3; 95% CI 19·5-46·9: RR 69·7 95% CI 45·8-106·1) compared with European/Other ethnicities.

Interpretation: The observation that GAS detection was markedly higher in Māori and Pacific Peoples provides a potential explanation for the marked ethnic differences in ARF. These findings support a greater focus on addressing the burden of skin infection in NZ, including as ARF prevention.

Funding: The first author received a training stipend from the New Zealand College of Public Health Medicine (NZCPHM) during her Masters of Public Health.

Citing Articles

The intricate pathogenicity of Group A : A comprehensive update.

Bergsten H, Nizet V Virulence. 2024; 15(1):2412745.

PMID: 39370779 PMC: 11542602. DOI: 10.1080/21505594.2024.2412745.

Research priorities for the primordial prevention of acute rheumatic fever and rheumatic heart disease by modifying the social determinants of health.

Baker M, Masterson M, Shung-King M, Beaton A, Bowen A, Bansal G BMJ Glob Health. 2023; 8(Suppl 9).

PMID: 37914185 PMC: 10619085. DOI: 10.1136/bmjgh-2023-012467.

Research opportunities for the primary prevention and management of acute rheumatic fever and rheumatic heart disease: a National Heart, Lung, and Blood Institute workshop report.

Rwebembera J, Cannon J, Sanyahumbi A, Sotoodehnia N, Taubert K, Yilgwan C BMJ Glob Health. 2023; 8(Suppl 9).

PMID: 37914184 PMC: 10619102. DOI: 10.1136/bmjgh-2023-012356.

Modalities of group A streptococcal prevention and treatment and their economic justification.

Cannon J, Wyber R NPJ Vaccines. 2023; 8(1):59.

PMID: 37087467 PMC: 10122086. DOI: 10.1038/s41541-023-00649-3.

A pilot study to develop assessment tools for Group A Streptococcus surveillance studies.

Pickering J, Sampson C, Mullane M, Sheel M, Barth D, Lane M PeerJ. 2023; 11:e14945.

PMID: 36935916 PMC: 10022509. DOI: 10.7717/peerj.14945.

References

Lim A, Rumball-Smith J, Jones R, Kawachi I . The rise and fall of hospitalizations for skin infections in New Zealand, 2004-2014: trends by ethnicity and socioeconomic deprivation. Epidemiol Infect. 2016; 145(4):678-684. PMC: 9507719. DOI: 10.1017/S0950268816002685. View

Carapetis J, McDonald M, Wilson N . Acute rheumatic fever. Lancet. 2005; 366(9480):155-68. DOI: 10.1016/S0140-6736(05)66874-2. View

Jaine R, Baker M, Venugopal K . Epidemiology of acute rheumatic fever in New Zealand 1996-2005. J Paediatr Child Health. 2008; 44(10):564-71. DOI: 10.1111/j.1440-1754.2008.01384.x. View

Oliver J, Upton A, Jack S, Pierse N, Williamson D, Baker M . Distribution of Streptococcal Pharyngitis and Acute Rheumatic Fever, Auckland, New Zealand, 2010-2016. Emerg Infect Dis. 2020; 26(6):1113-1121. PMC: 7258449. DOI: 10.3201/eid2606.181462. View

Shaikh N, Leonard E, Martin J . Prevalence of streptococcal pharyngitis and streptococcal carriage in children: a meta-analysis. Pediatrics. 2010; 126(3):e557-64. DOI: 10.1542/peds.2009-2648. View

Baker M, Telfar Barnard L, Kvalsvig A, Verrall A, Zhang J, Keall M . Increasing incidence of serious infectious diseases and inequalities in New Zealand: a national epidemiological study. Lancet. 2012; 379(9821):1112-9. DOI: 10.1016/S0140-6736(11)61780-7. View

Bowen A, Mahe A, Hay R, Andrews R, Steer A, Tong S . The Global Epidemiology of Impetigo: A Systematic Review of the Population Prevalence of Impetigo and Pyoderma. PLoS One. 2015; 10(8):e0136789. PMC: 4552802. DOI: 10.1371/journal.pone.0136789. View

OSullivan C, Baker M, Zhang J, Davies A, Cramp G . The epidemiology of serious skin infections in New Zealand children: comparing the Tairawhiti region with national trends. N Z Med J. 2012; 125(1351):40-54. View

Steer A, Danchin M, Carapetis J . Group A streptococcal infections in children. J Paediatr Child Health. 2007; 43(4):203-13. DOI: 10.1111/j.1440-1754.2007.01051.x. View

10.

Milne R, Lennon D, Stewart J, Vander Hoorn S, Scuffham P . Incidence of acute rheumatic fever in New Zealand children and youth. J Paediatr Child Health. 2012; 48(8):685-91. DOI: 10.1111/j.1440-1754.2012.02447.x. View

11.

Martin D, Voss L, Walker S, Lennon D . Acute rheumatic fever in Auckland, New Zealand: spectrum of associated group A streptococci different from expected. Pediatr Infect Dis J. 1994; 13(4):264-9. DOI: 10.1097/00006454-199404000-00004. View

12.

Denis O . Route of transmission of Staphylococcus aureus. Lancet Infect Dis. 2016; 17(2):124-125. DOI: 10.1016/S1473-3099(16)30512-6. View

13.

Parks T, Smeesters P, Steer A . Streptococcal skin infection and rheumatic heart disease. Curr Opin Infect Dis. 2012; 25(2):145-53. DOI: 10.1097/QCO.0b013e3283511d27. View

14.

OSullivan C, Baker M, Zhang J . Increasing hospitalizations for serious skin infections in New Zealand children, 1990-2007. Epidemiol Infect. 2010; 139(11):1794-804. DOI: 10.1017/S0950268810002761. View

15.

Swe P, Christian L, Lu H, Sriprakash K, Fischer K . Complement inhibition by Sarcoptes scabiei protects Streptococcus pyogenes - An in vitro study to unravel the molecular mechanisms behind the poorly understood predilection of S. pyogenes to infect mite-induced skin lesions. PLoS Negl Trop Dis. 2017; 11(3):e0005437. PMC: 5360341. DOI: 10.1371/journal.pntd.0005437. View

16.

Brandt E, Yarwood P, McMillan D, Vohra H, Currie B, Mammo L . Antibody levels to the class I and II epitopes of the M protein and myosin are related to group A streptococcal exposure in endemic populations. Int Immunol. 2001; 13(10):1335-43. DOI: 10.1093/intimm/13.10.1335. View

17.

McDonald M, Brown A, Edwards T, Hope A, Amu M, Morey F . Apparent contrasting rates of pharyngitis and pyoderma in regions where rheumatic heart disease is highly prevalent. Heart Lung Circ. 2007; 16(4):254-9. DOI: 10.1016/j.hlc.2007.02.087. View

18.

Bowen A, Tong S, Chatfield M, Carapetis J . The microbiology of impetigo in indigenous children: associations between Streptococcus pyogenes, Staphylococcus aureus, scabies, and nasal carriage. BMC Infect Dis. 2015; 14:727. PMC: 4299569. DOI: 10.1186/s12879-014-0727-5. View

19.

McDonald M, Currie B, Carapetis J . Acute rheumatic fever: a chink in the chain that links the heart to the throat?. Lancet Infect Dis. 2004; 4(4):240-5. DOI: 10.1016/S1473-3099(04)00975-2. View

20.

Bennett J, Zhang J, Leung W, Jack S, Oliver J, Webb R . Rising Ethnic Inequalities in Acute Rheumatic Fever and Rheumatic Heart Disease, New Zealand, 2000-2018. Emerg Infect Dis. 2020; 27(1). PMC: 7774562. DOI: 10.3201/eid2701.191791. View